Allogene Therapeutics, Inc. ( ALLO) - Stock Earnings
ALLO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
ALLO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -38.8 million USD | — USD |
| 2026Q1 | -42.6 million USD | — USD |
| 2026Q2 | -42.7 million USD | 4.6 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ALLO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -327.3 million USD | 95000 USD |
| 2024 | -257.6 million USD | 22000 USD |
| 2025 | -190.9 million USD | — USD |
| 2026 Est. | — | — |
ALLO
Price: $1.31
52 week price:
Earnings Per Share: -0.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 358933
Market Capitalization: 503.9 million